Bacterial contamination of an automated pharmacy robot used for intravenous medication preparation

Area of Science:

• Microbiology
• Pharmaceutical Science
• Healthcare Quality Assurance

Background:

• Pharmacy automation, including robotic systems for intravenous (IV) medication compounding, is increasingly adopted to enhance efficiency and reduce errors.
• Routine quality assurance (QA) testing is critical for ensuring the sterility and safety of compounded medications.
• Potential contamination sources in automated compounding environments require thorough investigation.

Purpose of the Study:

• To report the findings of an investigation into Bacillus cereus contamination identified during routine QA testing.
• To document the contamination of both the pharmacy robot and the IV drug products it prepared.
• To describe the investigation process and its outcomes.

Main Methods:

• Cultures were performed as part of routine quality assurance testing.
• Positive cultures for Bacillus cereus prompted a detailed investigation.
• Sampling and testing of the pharmacy robot and prepared drug products were conducted.

Main Results:

• Routine QA testing revealed multiple positive cultures for Bacillus cereus.
• The investigation confirmed bacterial contamination of the pharmacy robot.
• Drug products prepared by the contaminated robot were also found to be contaminated.

Conclusions:

• Bacillus cereus contamination posed a risk to patient safety through compromised IV medications.
• The findings highlight the importance of rigorous QA testing for automated pharmaceutical compounding systems.
• Effective containment and remediation strategies are essential to prevent recurrence of such contamination events.